Cargando…

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19

Detalles Bibliográficos
Autores principales:	Chuang, Tzu-Yi, Tsai, Ming-Han, Wu, Lit-Min, Ho, Sung-Jung, Yeh, Pu-Sheng, Liu, Yi-Lien, Fred Yang, Hung-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837228/ https://www.ncbi.nlm.nih.gov/pubmed/34756359 http://dx.doi.org/10.1016/j.jmii.2020.09.007

Ejemplares similares

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Standard Dose Ivermectin for COVID-19
por: Buonfrate, Dora, et al.
Publicado: (2021)

VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

Ivermectin in COVID-19. Argumentun ad ignorantiam?()
por: Carlosama-Rosero, Y.
Publicado: (2020)

Tuberculosis complicated by ARDS
por: Arevalo-Lorido, J. C., et al.
Publicado: (2001)

Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?()
por: López Reboiro, M.L., et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Lepper, Philipp M, et al.
Publicado: (2021)

Lung transplantation for COVID-19-associated ARDS
por: Messika, Jonathan, et al.
Publicado: (2021)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

Prone Positioning in COVID-19 ARDS: Reply
por: Zarantonello, Francesco, et al.
Publicado: (2023)

Prone Positioning in COVID-19 ARDS: Comment
por: Zhao, Zhanqi, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose
por: Jain, Siddharth, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
por: Teng, Fei, et al.
Publicado: (2021)

Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection
por: Boven, A G, et al.
Publicado: (2021)

Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
por: Temple, Courtney, et al.
Publicado: (2021)

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
por: Hagiya, Hideharu, et al.
Publicado: (2021)

There is no place (yet) for routine administration of sildenafil to patients with ARDS
por: Cornet, Alexander D., et al.
Publicado: (2010)

COVID-19 and ARDS: the baby lung size matters
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Complexity and unanswered questions in the pathophysiology of COVID-19 ARDS
por: Chiumello, Davide, et al.
Publicado: (2021)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019
por: Mombrun, Martin, et al.
Publicado: (2021)

Remarks About Retrospective Analysis of Ivermectin Effectiveness on Coronavirus Disease 2019 (ICON Study)
por: Ortega-Guillén, Eduardo, et al.
Publicado: (2021)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
por: Carlet, Jean, et al.
Publicado: (2020)

Lung recruitability in ARDS H1N1 patients
por: Chiumello, D., et al.
Publicado: (2010)

Lung transplantation for COVID-19-associated ARDS – Authors' reply
por: Bharat, Ankit, et al.
Publicado: (2021)

Anatomical, physiological and clinical similarities and differences in ARDS physiological subtypes
por: Jha, Ajay Kumar
Publicado: (2021)

COVID-19 ARDS: getting ventilation right – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2022)

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma
por: Eberst, Lauriane, et al.
Publicado: (2020)

First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
por: Mastroianni, Fiore
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021)

Recurrent Hemorrhagic Pericardial Effusion and Tamponade due to Filariasis Successfully Treated with Ivermectin and Albendazole
por: Sinha, Santosh Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_br64oa38gnfjh70oe8gecv5fhp